NasdaqGM - Nasdaq Real Time Price USD

Ocular Therapeutix, Inc. (OCUL)

5.04 -0.03 (-0.69%)
As of 1:44 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
58,443.00
58,443.00
51,494.00
43,522.00
17,403.00
Cost of Revenue
5,281.00
5,281.00
4,540.00
4,406.00
2,083.00
Gross Profit
53,162.00
53,162.00
46,954.00
39,116.00
15,320.00
Operating Expense
135,544.00
135,544.00
125,608.00
117,153.00
78,167.00
Operating Income
-82,382.00
-82,382.00
-78,654.00
-78,037.00
-62,847.00
Net Non Operating Interest Income Expense
-7,355.00
-7,355.00
-6,224.00
-6,638.00
-6,600.00
Other Income Expense
9,001.00
9,001.00
13,840.00
78,122.00
-86,189.00
Pretax Income
-80,736.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
Net Income Common Stockholders
-80,736.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
Average Dilution Earnings
-6,233.00
-6,233.00
-9,245.00
-73,712.00
--
Diluted NI Available to Com Stockholders
-86,969.00
-86,969.00
-80,283.00
-80,265.00
-155,636.00
Basic EPS
-1.01
--
-0.92
-0.09
-2.56
Diluted EPS
-1.02
--
-0.97
-0.98
-2.56
Basic Average Shares
79,827.36
--
76,875.04
76,392.87
60,752.23
Diluted Average Shares
85,596.59
--
82,644.27
82,162.10
60,752.23
Total Operating Income as Reported
-82,382.00
-82,382.00
-78,654.00
-78,037.00
-62,847.00
Total Expenses
140,825.00
140,825.00
130,148.00
121,559.00
80,250.00
Net Income from Continuing & Discontinued Operation
-80,736.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
Normalized Income
-89,738.00
-89,738.00
-84,879.00
-84,674.00
-69,447.00
Interest Income
3,983.00
3,983.00
798.00
33.00
168.00
Interest Expense
11,338.00
11,338.00
7,022.00
6,671.00
6,768.00
Net Interest Income
-7,355.00
-7,355.00
-6,224.00
-6,638.00
-6,600.00
EBIT
-69,398.00
-69,398.00
-64,016.00
118.00
-148,868.00
EBITDA
-66,415.00
-66,415.00
-61,907.00
2,539.00
-146,095.00
Reconciled Cost of Revenue
5,281.00
5,281.00
4,540.00
4,406.00
2,083.00
Reconciled Depreciation
2,983.00
2,983.00
2,109.00
2,421.00
2,773.00
Net Income from Continuing Operation Net Minority Interest
-80,736.00
-80,736.00
-71,038.00
-6,553.00
-155,636.00
Total Unusual Items Excluding Goodwill
9,002.00
9,002.00
13,841.00
78,121.00
-86,189.00
Total Unusual Items
9,002.00
9,002.00
13,841.00
78,121.00
-86,189.00
Normalized EBITDA
-75,417.00
-75,417.00
-75,748.00
-75,582.00
-59,906.00
12/31/2020 - 7/25/2014
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

EYPT EyePoint Pharmaceuticals, Inc.
18.00
+6.19%
 
DAWN Day One Biopharmaceuticals, Inc.
16.50
+7.26%
 
TGTX TG Therapeutics, Inc.
14.54
+3.12%
 
SAGE Sage Therapeutics, Inc.
12.87
-0.16%
 
ABEO Abeona Therapeutics Inc.
3.4000
-53.80%
 
PDSB PDS Biotechnology Corporation
3.2000
+7.01%
 
CYTK Cytokinetics, Incorporated
66.09
-0.31%
 
MREO Mereo BioPharma Group plc
2.8200
+1.08%
 
CGEM Cullinan Therapeutics, Inc.
16.74
+7.07%
 
BHVN Biohaven Ltd.
39.88
+4.04%